Skip to main content

Table 1 Baseline Characteristics of Completers and non-Completers:

From: Lung function in idiopathic pulmonary fibrosis - extended analyses of the IFIGENIA trial

   Completers (N = 106) Non completers (N = 33) p value
All patients [n(%)]   106 (100.0%) 33 (100.0%)  
Gender [n(%)] Male 74 (69.8%) 25 (75.8%) 0.5100
  Female 32 (30.2%) 8 (24.2%)  
Age (Year)   62.1 (9.0) 64.2 (8.3) 0.2219
Duration of symptoms (Month) 42.6 (44.4) 35.1 (34.9) 0.3812
Pretreatment [n(%)] No 52 (49.1%) 17 (51.5%) 0.8052
  Yes 54 (50.9%) 16 (48.5%)  
New diagnosis? [n(%)] No 71 (67.0%) 16 (48.5%) 0.0552
  Yes 35 (33.0%) 17 (51.5%)  
Surgical lung biopsy [n(%)] No 59 (55.7) 16 (48.5%) 0.1794
  Yes 47 (44.3%) 17 (51.5%)  
Baseline VC [l] 2.38 (0.72) 2.14 (0.65) 0.0901
Baseline DLCo [mmol/min/kPa]   4.03 (1.33) 3.07 (1.34) 0.0004 ***
Baseline TLC [l]   3.78 (0.98) 3.34 (0.89) 0.0261 *
Baseline PaO 2 [mmHg]   73.23 (11.11) 66.98 (13.66) 0.0093 **
Baseline P(A-a)O 2 [mmHg]   30.79 (13.82) 38.88 (25.17) 0.0376 *
Baseline FEV1/VC   0.840 (0.081) 0.841 (0.076) 0.9026
Baseline CPI   49.20 (10.71) 57.00 (9.75) 0.0003 ***
  1. *: p < 0.05; **: p < 0.01; ***: p < 0.001;